Neuros Medical

Country:
USA
Founding year:
2008

Neuros Medical is a neurotechnology company developing an implantable neuromodulation therapy designed to treat chronic pain without drugs or brain stimulation. The company focuses on peripheral nerve modulation as an alternative to opioid-based pain management.

Its core technology, Altius®, uses high-frequency electrical stimulation applied to peripheral nerves to selectively block pain signals while preserving normal nerve function. The system is fully implantable and is designed to be programmed and adjusted to individual patient needs.

Neuros Medical’s technology is intended for clinical use in patients with chronic post-amputation pain and other peripheral neuropathic pain conditions. The company positions its platform as a targeted neuromodulation therapy that addresses pain at the nerve level rather than through central nervous system intervention.

Neuromodulation
Therapeutics
Clinical Workflows

Neurofounders Insights

Modality:
Nerve stimulator
Form Factor:
External device
Interface Depth:
Non-invasive
Indication:
Pain/migraine
Target user:
Patients
Regulatory stage:
FDA approved (PMA)

Series C+

Neuros Medical is differentiated by its use of high-frequency electrical nerve block for chronic pain, targeting signal suppression rather than conventional stimulatory modulation. This mechanistic distinction gives it a clearer identity within the broader pain neuromodulation market.

Related companies

Articles featuring

Neuros Medical

No articles yet!

Press releases

No press releases published yet.